BRAIN Biotech AG (XTER:BNN) Price-to-Operating-Cash-Flow : (As of Jun. 08, 2024)

View and export this data going back to 2016. Start your Free Trial

What is BRAIN Biotech AG Price-to-Operating-Cash-Flow?

As of today (2024-06-08), BRAIN Biotech AG's share price is €2.77. BRAIN Biotech AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.09. Hence, BRAIN Biotech AG's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for BRAIN Biotech AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

XTER:BNN's Price-to-Operating-Cash-Flow is not ranked ^*
in the Chemicals industry.
Industry Median: 13.25
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

BRAIN Biotech AG's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.09.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 8.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 14.60% per year.

During the past 9 years, BRAIN Biotech AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 31.20% per year. The lowest was 2.10% per year. And the median was 11.55% per year.

BRAIN Biotech AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for BRAIN Biotech AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BRAIN Biotech AG Price-to-Operating-Cash-Flow Chart

BRAIN Biotech AG Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

BRAIN Biotech AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BRAIN Biotech AG's Price-to-Operating-Cash-Flow

For the Specialty Chemicals subindustry, BRAIN Biotech AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BRAIN Biotech AG's Price-to-Operating-Cash-Flow Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, BRAIN Biotech AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BRAIN Biotech AG's Price-to-Operating-Cash-Flow falls into.

BRAIN Biotech AG Price-to-Operating-Cash-Flow Calculation

BRAIN Biotech AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	2.77	/	-0.085
	=

BRAIN Biotech AG's Share Price of today is €2.77.
BRAIN Biotech AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.09.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

BRAIN Biotech AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BRAIN Biotech AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

BRAIN Biotech AG (XTER:BNN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BRAIN Biotech AG (XTER:BNN) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BNN:Germany BNN:Germany BNN:Germany

Address

Darmstadter Strasse 34-36, Zwingenberg, BW, DEU, 64673

Website

https://www.brain-biotech.com

BRAIN Biotech AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. The company's segments include, BioProducts, BioScience and BioIncubator. Majority of the revenue is generated from its BioProducts segment which comprises of the product business with enzymes and other proteins for specific segments of the food industry. Geographically, the company generates majority of the revenue from United States of America and also has presence in other markets such as, Germany, France, United Kingdom and Netherlands.

Executives

Dr. Michael Majerus	Supervisory Board
Dr. Georg Kellinghusen	Supervisory Board
Michael Schneiders	Board of Directors
Adriaan Moelker	Board of Directors
Lukas Linnig	Board of Directors

BRAIN Biotech AG (XTER:BNN) Headlines

No Headlines